REBECCA Real-world Early BrEast CanCer mAnagement

Recruiting now

Conditions studied: Breast Cancer

In brief

This is a French observational, national, multicenter prospective cohort study of patients with HER2-negative eBC treated with olaparib at their physician's discretion.

Key facts

Study ID

NCT06856343

Run by

AstraZeneca

People needed

126

Starts

2024-12-30

Expected to finish

2028-01-31

Last updated by the study team

2026-07-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female aged ≥ 18 years
• Patient diagnosed with HER2-negative eBC
• Patient about to be initiated with adjuvant Olaparib at their physician's discretion
• Patient has been informed and does not object to participation in the study.

You may not qualify if…

• Patient not consenting to participate.
• Patients included in the Early Access Program

Where it is running

• Research Site — Caen, Normandy, France (enrolling)
• Research Site — Perpignan, Occitanie, France (enrolling)
• Research Site — Salouël, Hauts-de-France, France (enrolling)
• Research Site — Poitiers, New Aquitaine, France (enrolling)
• Research Site — Montpellier, Occitanie, France (enrolling)
• Research Site — Nîmes, Occitanie, France (enrolling)
• Research Site — Thonon-les-Bains, Auvergne-Rh ne-Alpes, France (enrolling)
• Research Site — Lyon, Auvergne-Rh ne-Alpes, France (enrolling)
• Research Site — Metz-Tessy, Auvergne-Rh ne-Alpes, France (enrolling)
• Research Site — Périgueux, New Aquitaine, France (enrolling)
• Research Site — Rouen, Normandy, France (enrolling)
• Research Site — Clermont-Ferrand, Auvergne-Rh ne-Alpes, France (enrolling)
• Research Site — Montpellier, Occitanie, France (enrolling)
• Research Site — Saint-Grégoire, Brittany Region, France (enrolling)
• Research Site — Chambray-lès-Tours, Centre-Val de Loire, France (enrolling)
• Research Site — Saint-Doulchard, Centre-Val de Loire, France (enrolling)
• Research Site — Bezannes, Grand Est, France (enrolling)
• Research Site — Valence, Auvergne-Rh ne-Alpes, France (enrolling)
• Research Site — Nancy, Grand Est, France (enrolling)
• Research Site — Beauvais, Hauts-de-France, France (enrolling)
• Research Site — Beuvry, Hauts-de-France, France (enrolling)
• Research Site — Gleizé, Auvergne-Rh ne-Alpes, France (enrolling)
• Research Site — Plérin, Brittany Region, France (enrolling)
• Research Site — Dechy, Hauts-de-France, France (enrolling)
• Research Site — Toulouse, Occitanie, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.